Creative Medical Technology Holdings (CELZ) Return on Sales (2017 - 2025)
Historic Return on Sales for Creative Medical Technology Holdings (CELZ) over the last 9 years, with Q3 2025 value amounting to 993.57%.
- Creative Medical Technology Holdings' Return on Sales fell 5101200.0% to 993.57% in Q3 2025 from the same period last year, while for Sep 2025 it was 993.57%, marking a year-over-year decrease of 5101200.0%. This contributed to the annual value of 499.41% for FY2024, which is 879900.0% up from last year.
- Creative Medical Technology Holdings' Return on Sales amounted to 993.57% in Q3 2025, which was down 5101200.0% from 960.93% recorded in Q2 2025.
- Creative Medical Technology Holdings' Return on Sales' 5-year high stood at 17.86% during Q3 2022, with a 5-year trough of 993.57% in Q3 2025.
- Moreover, its 5-year median value for Return on Sales was 242.33% (2023), whereas its average is 347.62%.
- Its Return on Sales has fluctuated over the past 5 years, first soared by 21639900bps in 2021, then crashed by -7662200bps in 2025.
- Creative Medical Technology Holdings' Return on Sales (Quarter) stood at 57.2% in 2021, then crashed by -484bps to 334.18% in 2022, then tumbled by -67bps to 559.52% in 2023, then dropped by -10bps to 618.02% in 2024, then crashed by -61bps to 993.57% in 2025.
- Its Return on Sales was 993.57% in Q3 2025, compared to 960.93% in Q2 2025 and 546.03% in Q1 2025.